127 related articles for article (PubMed ID: 2724305)
1. New cyclic peptides with cytotoxic activity from the ascidian Lissoclinum patella.
Degnan BM; Hawkins CJ; Lavin MF; McCaffrey EJ; Parry DL; van den Brenk AL; Watters DJ
J Med Chem; 1989 Jun; 32(6):1349-54. PubMed ID: 2724305
[TBL] [Abstract][Full Text] [Related]
2. Novel cytotoxic compounds from the ascidian Lissoclinum bistratum.
Degnan BM; Hawkins CJ; Lavin MF; McCaffrey EJ; Parry DL; Watters DJ
J Med Chem; 1989 Jun; 32(6):1354-9. PubMed ID: 2724306
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of the lissoclinamides: cytotoxic cyclic peptides from the ascidian Lissoclinum patella.
Hawkins CJ; Lavin MF; Marshall KA; van den Brenk AL; Watters DJ
J Med Chem; 1990 Jun; 33(6):1634-8. PubMed ID: 2342056
[TBL] [Abstract][Full Text] [Related]
4. Patellamide E: a new cyclic peptide from the ascidian Lissoclinum patella.
McDonald LA; Ireland CM
J Nat Prod; 1992 Mar; 55(3):376-9. PubMed ID: 1593285
[TBL] [Abstract][Full Text] [Related]
5. Patellamide F, A new cytotoxic cyclic peptide from the colonial ascidian Lissoclinum patella.
Rashid MA; Gustafson KR; Cardellina JH; Boyd MR
J Nat Prod; 1995 Apr; 58(4):594-7. PubMed ID: 7623037
[TBL] [Abstract][Full Text] [Related]
6. Localization studies of ioactive cyclic peptides in the ascidian Lissoclinum patella.
Salomon CE; Faulkner DJ
J Nat Prod; 2002 May; 65(5):689-92. PubMed ID: 12027743
[TBL] [Abstract][Full Text] [Related]
7. Molecular conformation of patellamide A, a cytotoxic cyclic peptide from the ascidian Lissoclinum patella, by X-ray crystal analysis.
In Y; Doi M; Inoue M; Ishida T; Hamada Y; Shioiri T
Chem Pharm Bull (Tokyo); 1993 Oct; 41(10):1686-90. PubMed ID: 8281568
[TBL] [Abstract][Full Text] [Related]
8. New cyclic peptides from the ascidian Lissoclinum patella.
Fu X; Do T; Schmitz FJ; Andrusevich V; Engel MH
J Nat Prod; 1998 Dec; 61(12):1547-51. PubMed ID: 9868162
[TBL] [Abstract][Full Text] [Related]
9. Patellamide A and C biosynthesis by a microcin-like pathway in Prochloron didemni, the cyanobacterial symbiont of Lissoclinum patella.
Schmidt EW; Nelson JT; Rasko DA; Sudek S; Eisen JA; Haygood MG; Ravel J
Proc Natl Acad Sci U S A; 2005 May; 102(20):7315-20. PubMed ID: 15883371
[TBL] [Abstract][Full Text] [Related]
10. Bistratamides E-J, modified cyclic hexapeptides from the Philippines ascidian Lissoclinum bistratum.
Perez LJ; Faulkner DJ
J Nat Prod; 2003 Feb; 66(2):247-50. PubMed ID: 12608858
[TBL] [Abstract][Full Text] [Related]
11. Patellamide A, a cytotoxic cyclic peptide from the ascidian Lissoclinum patella.
In Y; Doi M; Inoue M; Ishida T; Hamada Y; Shioiri T
Acta Crystallogr C; 1994 Mar; 50 ( Pt 3)():432-4. PubMed ID: 8018309
[TBL] [Abstract][Full Text] [Related]
12. Bistratamides M and N, Oxazole-Thiazole Containing Cyclic Hexapeptides Isolated from Lissoclinum bistratum Interaction of Zinc (II) with Bistratamide K.
Urda C; Fernández R; Rodríguez J; Pérez M; Jiménez C; Cuevas C
Mar Drugs; 2017 Jul; 15(7):. PubMed ID: 28671564
[TBL] [Abstract][Full Text] [Related]
13. Didmolamide A and B, two new cyclic hexapeptides from the marine ascidian Didemnum molle.
Rudi A; Chill L; Aknin M; Kashman Y
J Nat Prod; 2003 Apr; 66(4):575-7. PubMed ID: 12713422
[TBL] [Abstract][Full Text] [Related]
14. Haterumaimides F-I, four new cytotoxic diterpene alkaloids from an ascidian Lissoclinum species.
Uddin MJ; Kokubo S; Ueda K; Suenaga K; Uemura D
J Nat Prod; 2001 Sep; 64(9):1169-73. PubMed ID: 11575950
[TBL] [Abstract][Full Text] [Related]
15. The structure of ulithiacyclamide B. Antitumor evaluation of cyclic peptides and macrolides from Lissoclinum patella.
Williams DE; Moore RE; Paul VJ
J Nat Prod; 1989; 52(4):732-9. PubMed ID: 2809606
[TBL] [Abstract][Full Text] [Related]
16. Formation of mononuclear and chloro-bridged binuclear copper(II) complexes of patellamide D, a naturally occurring cyclic peptide: influence of anion and solvent.
van den Brenk AL; Tyndall JD; Cusack RM; Jones A; Fairlie DP; Gahan LR; Hanson GR
J Inorg Biochem; 2004 Nov; 98(11):1857-66. PubMed ID: 15522413
[TBL] [Abstract][Full Text] [Related]
17. Possible Functional Roles of Patellamides in the Ascidian-
Baur P; Kühl M; Comba P; Behrendt L
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200648
[TBL] [Abstract][Full Text] [Related]
18. Lissoclinolide, the first non-nitrogenous metabolite from a Lissoclinum tunicate.
Davidson BS; Ireland CM
J Nat Prod; 1990; 53(4):1036-8. PubMed ID: 2095371
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic labdane alkaloids from an ascidian Lissoclinum sp.: isolation, structure elucidation, and structure-activity relationship.
Uddin J; Ueda K; Siwu ER; Kita M; Uemura D
Bioorg Med Chem; 2006 Oct; 14(20):6954-61. PubMed ID: 16854586
[TBL] [Abstract][Full Text] [Related]
20. Tamandarins A and B: new cytotoxic depsipeptides from a Brazilian ascidian of the family Didemnidae.
Vervoort H; Fenical W; Epifanio RA
J Org Chem; 2000 Feb; 65(3):782-92. PubMed ID: 10814011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
